Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Discovery & Development

    Er-Kim to distribute Nerlynx in CIS and Eastern Europe to improve HER2-positive breast cancer treatment access

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    BridgeBio sees strong launch for ATTR-CM drug Attruby and accelerates rare disease pipeline

    BridgeBio Pharma reported $36.7 million in US net revenue for [...]

    May 5, 2026
  • Drug Discovery & Development

    Glen Clova Scientific relocates R&D operations to support pipeline expansion

    Glen Clova Scientific has moved its R&D operations to the [...]

    May 5, 2026
  • Drug Discovery & Development

    Landmark BioVentures and G.CLIPS Biotech join forces to tackle drug target engagement bottlenecks

    May 5, 2026
Previous7879

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections
    Categories: Clinical & Regulatory, Digital & Data, Genomics and sequencing, Research & Development
  • Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Latent Labs opens lab-validated AI drug design platform to researchers worldwide
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top